nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA2D2—mammary gland—breast cancer	0.0106	0.0934	CbGeAlD
Gabapentin—CACNA2D1—mammary gland—breast cancer	0.00765	0.0672	CbGeAlD
Gabapentin—CACNA1B—pituitary gland—breast cancer	0.00667	0.0585	CbGeAlD
Gabapentin—BCAT1—endometrium—breast cancer	0.00579	0.0509	CbGeAlD
Gabapentin—BCAT1—uterus—breast cancer	0.00534	0.0469	CbGeAlD
Gabapentin—BCAT1—pituitary gland—breast cancer	0.00524	0.046	CbGeAlD
Gabapentin—BCAT1—adipose tissue—breast cancer	0.00522	0.0458	CbGeAlD
Gabapentin—CACNA2D2—pituitary gland—breast cancer	0.00481	0.0422	CbGeAlD
Gabapentin—BCAT1—female reproductive system—breast cancer	0.0048	0.0421	CbGeAlD
Gabapentin—BCAT1—adrenal gland—breast cancer	0.00468	0.0411	CbGeAlD
Gabapentin—BCAT1—female gonad—breast cancer	0.00437	0.0383	CbGeAlD
Gabapentin—CACNA2D2—adrenal gland—breast cancer	0.00429	0.0377	CbGeAlD
Gabapentin—BCAT1—endocrine gland—breast cancer	0.00406	0.0357	CbGeAlD
Gabapentin—CACNA2D2—endocrine gland—breast cancer	0.00372	0.0327	CbGeAlD
Gabapentin—CACNA1B—lymph node—breast cancer	0.00357	0.0313	CbGeAlD
Gabapentin—CACNA2D1—adipose tissue—breast cancer	0.00344	0.0302	CbGeAlD
Gabapentin—ADORA1—adipose tissue—breast cancer	0.00332	0.0292	CbGeAlD
Gabapentin—CACNA2D1—adrenal gland—breast cancer	0.00309	0.0271	CbGeAlD
Gabapentin—ADORA1—female reproductive system—breast cancer	0.00305	0.0268	CbGeAlD
Gabapentin—CACNA2D1—bone marrow—breast cancer	0.00299	0.0262	CbGeAlD
Gabapentin—CACNA2D1—female gonad—breast cancer	0.00288	0.0253	CbGeAlD
Gabapentin—BCAT1—lymph node—breast cancer	0.00281	0.0246	CbGeAlD
Gabapentin—CACNA2D1—endocrine gland—breast cancer	0.00268	0.0235	CbGeAlD
Gabapentin—ADORA1—endocrine gland—breast cancer	0.00258	0.0227	CbGeAlD
Gabapentin—CACNA2D2—lymph node—breast cancer	0.00257	0.0226	CbGeAlD
Gabapentin—CACNA2D1—lymph node—breast cancer	0.00185	0.0163	CbGeAlD
Gabapentin—ADORA1—lymph node—breast cancer	0.00179	0.0157	CbGeAlD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR2—breast cancer	0.00012	0.000767	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—WNT10B—breast cancer	0.000119	0.000762	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—WWOX—breast cancer	0.000119	0.000762	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—WNT1—breast cancer	0.000119	0.000762	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCB1—breast cancer	0.000119	0.00076	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTHLH—breast cancer	0.000119	0.000758	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA3—breast cancer	0.000119	0.000758	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A2—breast cancer	0.000118	0.000753	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TYMS—breast cancer	0.000117	0.000746	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—breast cancer	0.000116	0.000743	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INHBB—breast cancer	0.000116	0.000742	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDE2A—breast cancer	0.000116	0.000742	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL27—breast cancer	0.000116	0.000742	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL3—breast cancer	0.000116	0.000742	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCG2—breast cancer	0.000115	0.000737	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CPT1A—breast cancer	0.000115	0.000737	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTR—breast cancer	0.000115	0.000737	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—breast cancer	0.000115	0.000737	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NCOR1—breast cancer	0.000115	0.000737	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLA2G4A—breast cancer	0.000115	0.000737	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDNRB—breast cancer	0.000115	0.000734	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HPGDS—breast cancer	0.000113	0.000723	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HBA1—breast cancer	0.000112	0.000719	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BMPR2—breast cancer	0.000111	0.000708	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DLL4—breast cancer	0.000111	0.000708	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPX1—breast cancer	0.00011	0.000706	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—breast cancer	0.00011	0.000701	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ACHE—breast cancer	0.00011	0.000701	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1A1—breast cancer	0.000109	0.000699	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL2—breast cancer	0.000109	0.000696	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGTR2—breast cancer	0.000109	0.000696	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ERCC2—breast cancer	0.000108	0.000693	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTHLH—breast cancer	0.000108	0.000689	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDH5—breast cancer	0.000106	0.000679	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CALCA—breast cancer	0.000104	0.000668	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDNRB—breast cancer	0.000104	0.000667	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SFRP2—breast cancer	0.000104	0.000666	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP17A1—breast cancer	0.000104	0.000664	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS1—breast cancer	0.000103	0.000657	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ENO1—breast cancer	0.000103	0.000657	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRLR—breast cancer	0.000102	0.000654	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR4—breast cancer	0.000102	0.000652	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL12—breast cancer	0.000102	0.000652	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—breast cancer	0.000102	0.000652	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2D6—breast cancer	0.000101	0.000645	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA2—breast cancer	9.89e-05	0.000633	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GLI2—breast cancer	9.87e-05	0.000631	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VCP—breast cancer	9.87e-05	0.000631	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	9.82e-05	0.000628	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEPR—breast cancer	9.71e-05	0.000621	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FASN—breast cancer	9.59e-05	0.000614	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BCHE—breast cancer	9.55e-05	0.000611	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CALCA—breast cancer	9.48e-05	0.000606	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC5A5—breast cancer	9.44e-05	0.000604	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAV1—breast cancer	9.4e-05	0.000601	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCR4—breast cancer	9.26e-05	0.000592	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL12—breast cancer	9.26e-05	0.000592	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR1—breast cancer	9.22e-05	0.00059	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NQO1—breast cancer	9.11e-05	0.000583	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A1—breast cancer	9.11e-05	0.000583	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ARHGDIA—breast cancer	9.03e-05	0.000577	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—breast cancer	8.9e-05	0.000569	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP3A4—breast cancer	8.89e-05	0.000568	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FST—breast cancer	8.8e-05	0.000563	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1B1—breast cancer	8.74e-05	0.000559	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HEY2—breast cancer	8.69e-05	0.000556	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RPS6KB2—breast cancer	8.59e-05	0.000549	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—breast cancer	8.59e-05	0.000549	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSP90AA1—breast cancer	8.57e-05	0.000548	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—breast cancer	8.56e-05	0.000548	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RGS2—breast cancer	8.49e-05	0.000543	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL20—breast cancer	8.39e-05	0.000537	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGTR1—breast cancer	8.37e-05	0.000536	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA1—breast cancer	8.33e-05	0.000533	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ITPR1—breast cancer	8.27e-05	0.000529	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—STK11—breast cancer	8.21e-05	0.000525	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP19A1—breast cancer	8.21e-05	0.000525	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TLE3—breast cancer	8.13e-05	0.00052	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPAR1—breast cancer	8.13e-05	0.00052	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HEY1—breast cancer	8.05e-05	0.000515	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DLL1—breast cancer	7.89e-05	0.000505	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—breast cancer	7.86e-05	0.000503	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIST1H2BK—breast cancer	7.74e-05	0.000495	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIST1H2BC—breast cancer	7.74e-05	0.000495	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRB7—breast cancer	7.67e-05	0.000491	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDE4D—breast cancer	7.67e-05	0.000491	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CSF2—breast cancer	7.64e-05	0.000489	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—COMT—breast cancer	7.64e-05	0.000489	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—breast cancer	7.6e-05	0.000486	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TAB2—breast cancer	7.54e-05	0.000483	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—breast cancer	7.53e-05	0.000481	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ITPR1—breast cancer	7.51e-05	0.000481	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—breast cancer	7.5e-05	0.00048	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CNR2—breast cancer	7.48e-05	0.000478	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ITPR1—breast cancer	7.48e-05	0.000478	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—breast cancer	7.47e-05	0.000478	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MMP3—breast cancer	7.46e-05	0.000477	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—breast cancer	7.43e-05	0.000475	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DKK1—breast cancer	7.3e-05	0.000467	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFC—breast cancer	7.24e-05	0.000463	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCB1—breast cancer	7.19e-05	0.00046	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAG2—breast cancer	7.14e-05	0.000456	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—breast cancer	7.11e-05	0.000455	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TYMS—breast cancer	7.07e-05	0.000452	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—WNT1—breast cancer	7.03e-05	0.00045	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PLA2G4A—breast cancer	7.02e-05	0.000449	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOR1—breast cancer	6.98e-05	0.000447	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLA2G4A—breast cancer	6.98e-05	0.000447	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—breast cancer	6.98e-05	0.000447	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CSF2—breast cancer	6.94e-05	0.000444	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPX1—breast cancer	6.69e-05	0.000428	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH4—breast cancer	6.67e-05	0.000426	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GZMB—breast cancer	6.63e-05	0.000424	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1A1—breast cancer	6.62e-05	0.000424	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ERCC2—breast cancer	6.57e-05	0.00042	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—breast cancer	6.56e-05	0.00042	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—breast cancer	6.5e-05	0.000416	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR2—breast cancer	6.43e-05	0.000411	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL2—breast cancer	6.43e-05	0.000411	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTHLH—breast cancer	6.36e-05	0.000407	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BMP2—breast cancer	6.36e-05	0.000407	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—breast cancer	6.17e-05	0.000395	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDNRB—breast cancer	6.16e-05	0.000394	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PGR—breast cancer	6.1e-05	0.00039	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—THBS1—breast cancer	6.07e-05	0.000388	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Docetaxel—breast cancer	5.79e-05	7.94e-05	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—breast cancer	5.79e-05	7.94e-05	CcSEcCtD
Gabapentin—Dyspnoea—Capecitabine—breast cancer	5.79e-05	7.94e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FLT1—breast cancer	5.79e-05	0.00037	CbGpPWpGaD
Gabapentin—Fatigue—Docetaxel—breast cancer	5.78e-05	7.93e-05	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—breast cancer	5.78e-05	7.92e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGF3—breast cancer	5.77e-05	0.000369	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SQSTM1—breast cancer	5.77e-05	0.000369	CbGpPWpGaD
Gabapentin—Nausea—Mitoxantrone—breast cancer	5.76e-05	7.9e-05	CcSEcCtD
Gabapentin—Nausea—Irinotecan—breast cancer	5.76e-05	7.9e-05	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—breast cancer	5.75e-05	7.88e-05	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—breast cancer	5.74e-05	7.87e-05	CcSEcCtD
Gabapentin—Pain—Docetaxel—breast cancer	5.74e-05	7.86e-05	CcSEcCtD
Gabapentin—Constipation—Docetaxel—breast cancer	5.74e-05	7.86e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—breast cancer	5.74e-05	0.000367	CbGpPWpGaD
Gabapentin—Back pain—Methotrexate—breast cancer	5.73e-05	7.85e-05	CcSEcCtD
Gabapentin—Dyspepsia—Capecitabine—breast cancer	5.72e-05	7.84e-05	CcSEcCtD
Gabapentin—Chills—Epirubicin—breast cancer	5.72e-05	7.83e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CAV1—breast cancer	5.69e-05	0.000364	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAG1—breast cancer	5.69e-05	0.000364	CbGpPWpGaD
Gabapentin—Visual impairment—Doxorubicin—breast cancer	5.68e-05	7.78e-05	CcSEcCtD
Gabapentin—Asthenia—Paclitaxel—breast cancer	5.68e-05	7.78e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PARP1—breast cancer	5.67e-05	0.000363	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH3—breast cancer	5.67e-05	0.000363	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—breast cancer	5.67e-05	0.000363	CbGpPWpGaD
Gabapentin—Decreased appetite—Capecitabine—breast cancer	5.65e-05	7.74e-05	CcSEcCtD
Gabapentin—Alopecia—Epirubicin—breast cancer	5.63e-05	7.71e-05	CcSEcCtD
Gabapentin—Nausea—Gemcitabine—breast cancer	5.62e-05	7.69e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Capecitabine—breast cancer	5.61e-05	7.68e-05	CcSEcCtD
Gabapentin—Fatigue—Capecitabine—breast cancer	5.6e-05	7.67e-05	CcSEcCtD
Gabapentin—Pruritus—Paclitaxel—breast cancer	5.6e-05	7.67e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CALCA—breast cancer	5.6e-05	0.000358	CbGpPWpGaD
Gabapentin—Vision blurred—Methotrexate—breast cancer	5.58e-05	7.65e-05	CcSEcCtD
Gabapentin—Mental disorder—Epirubicin—breast cancer	5.58e-05	7.65e-05	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—breast cancer	5.57e-05	7.64e-05	CcSEcCtD
Gabapentin—Pain—Capecitabine—breast cancer	5.55e-05	7.61e-05	CcSEcCtD
Gabapentin—Constipation—Capecitabine—breast cancer	5.55e-05	7.61e-05	CcSEcCtD
Gabapentin—Erythema—Epirubicin—breast cancer	5.54e-05	7.6e-05	CcSEcCtD
Gabapentin—Malnutrition—Epirubicin—breast cancer	5.54e-05	7.6e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—RPS6—breast cancer	5.53e-05	0.000354	CbGpPWpGaD
Gabapentin—Feeling abnormal—Docetaxel—breast cancer	5.53e-05	7.58e-05	CcSEcCtD
Gabapentin—Nausea—Fluorouracil—breast cancer	5.52e-05	7.57e-05	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—breast cancer	5.51e-05	7.55e-05	CcSEcCtD
Gabapentin—Ill-defined disorder—Methotrexate—breast cancer	5.5e-05	7.53e-05	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—breast cancer	5.49e-05	7.53e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGF4—breast cancer	5.49e-05	0.000351	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Docetaxel—breast cancer	5.49e-05	7.52e-05	CcSEcCtD
Gabapentin—Anaemia—Methotrexate—breast cancer	5.48e-05	7.5e-05	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—breast cancer	5.47e-05	7.49e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CXCR4—breast cancer	5.47e-05	0.00035	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL12—breast cancer	5.47e-05	0.00035	CbGpPWpGaD
Gabapentin—Flatulence—Epirubicin—breast cancer	5.46e-05	7.49e-05	CcSEcCtD
Gabapentin—Tension—Epirubicin—breast cancer	5.44e-05	7.46e-05	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—breast cancer	5.43e-05	7.44e-05	CcSEcCtD
Gabapentin—Diarrhoea—Paclitaxel—breast cancer	5.42e-05	7.42e-05	CcSEcCtD
Gabapentin—Nervousness—Epirubicin—breast cancer	5.39e-05	7.38e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PAK1—breast cancer	5.37e-05	0.000343	CbGpPWpGaD
Gabapentin—Back pain—Epirubicin—breast cancer	5.36e-05	7.35e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Capecitabine—breast cancer	5.35e-05	7.33e-05	CcSEcCtD
Gabapentin—Malaise—Methotrexate—breast cancer	5.34e-05	7.32e-05	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—breast cancer	5.33e-05	7.3e-05	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—breast cancer	5.32e-05	7.29e-05	CcSEcCtD
Gabapentin—Vertigo—Methotrexate—breast cancer	5.32e-05	7.29e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Capecitabine—breast cancer	5.31e-05	7.28e-05	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—breast cancer	5.31e-05	7.28e-05	CcSEcCtD
Gabapentin—Abdominal pain—Docetaxel—breast cancer	5.3e-05	7.27e-05	CcSEcCtD
Gabapentin—Body temperature increased—Docetaxel—breast cancer	5.3e-05	7.27e-05	CcSEcCtD
Gabapentin—Leukopenia—Methotrexate—breast cancer	5.3e-05	7.27e-05	CcSEcCtD
Gabapentin—Chills—Doxorubicin—breast cancer	5.29e-05	7.25e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TCF7L2—breast cancer	5.27e-05	0.000337	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT2—breast cancer	5.25e-05	0.000336	CbGpPWpGaD
Gabapentin—Dizziness—Paclitaxel—breast cancer	5.23e-05	7.17e-05	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—breast cancer	5.23e-05	7.16e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—breast cancer	5.21e-05	0.000333	CbGpPWpGaD
Gabapentin—Alopecia—Doxorubicin—breast cancer	5.21e-05	7.14e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—breast cancer	5.19e-05	0.000332	CbGpPWpGaD
Gabapentin—Cough—Methotrexate—breast cancer	5.17e-05	7.08e-05	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—breast cancer	5.16e-05	7.08e-05	CcSEcCtD
Gabapentin—Urticaria—Capecitabine—breast cancer	5.16e-05	7.07e-05	CcSEcCtD
Gabapentin—Ill-defined disorder—Epirubicin—breast cancer	5.14e-05	7.05e-05	CcSEcCtD
Gabapentin—Abdominal pain—Capecitabine—breast cancer	5.13e-05	7.04e-05	CcSEcCtD
Gabapentin—Body temperature increased—Capecitabine—breast cancer	5.13e-05	7.04e-05	CcSEcCtD
Gabapentin—Convulsion—Methotrexate—breast cancer	5.13e-05	7.03e-05	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—breast cancer	5.13e-05	7.03e-05	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—breast cancer	5.13e-05	7.03e-05	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—breast cancer	5.12e-05	7.02e-05	CcSEcCtD
Gabapentin—Agitation—Epirubicin—breast cancer	5.1e-05	6.98e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HSP90AA1—breast cancer	5.08e-05	0.000325	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH2—breast cancer	5.08e-05	0.000325	CbGpPWpGaD
Gabapentin—Flatulence—Doxorubicin—breast cancer	5.06e-05	6.93e-05	CcSEcCtD
Gabapentin—Myalgia—Methotrexate—breast cancer	5.04e-05	6.91e-05	CcSEcCtD
Gabapentin—Chest pain—Methotrexate—breast cancer	5.04e-05	6.91e-05	CcSEcCtD
Gabapentin—Arthralgia—Methotrexate—breast cancer	5.04e-05	6.91e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—breast cancer	5.04e-05	0.000323	CbGpPWpGaD
Gabapentin—Tension—Doxorubicin—breast cancer	5.03e-05	6.9e-05	CcSEcCtD
Gabapentin—Vomiting—Paclitaxel—breast cancer	5.03e-05	6.9e-05	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—breast cancer	5.02e-05	6.88e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.01e-05	6.86e-05	CcSEcCtD
Gabapentin—Malaise—Epirubicin—breast cancer	5e-05	6.85e-05	CcSEcCtD
Gabapentin—Rash—Paclitaxel—breast cancer	4.99e-05	6.84e-05	CcSEcCtD
Gabapentin—Dermatitis—Paclitaxel—breast cancer	4.99e-05	6.83e-05	CcSEcCtD
Gabapentin—Discomfort—Methotrexate—breast cancer	4.98e-05	6.83e-05	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—breast cancer	4.98e-05	6.83e-05	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—breast cancer	4.98e-05	6.83e-05	CcSEcCtD
Gabapentin—Syncope—Epirubicin—breast cancer	4.97e-05	6.81e-05	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—breast cancer	4.96e-05	6.8e-05	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—breast cancer	4.96e-05	6.8e-05	CcSEcCtD
Gabapentin—Headache—Paclitaxel—breast cancer	4.96e-05	6.79e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PRL—breast cancer	4.95e-05	0.000316	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR1—breast cancer	4.95e-05	0.000316	CbGpPWpGaD
Gabapentin—Hypersensitivity—Docetaxel—breast cancer	4.94e-05	6.77e-05	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—breast cancer	4.93e-05	6.76e-05	CcSEcCtD
Gabapentin—Palpitations—Epirubicin—breast cancer	4.9e-05	6.71e-05	CcSEcCtD
Gabapentin—Confusional state—Methotrexate—breast cancer	4.88e-05	6.68e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ADAM10—breast cancer	4.87e-05	0.000312	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STK11—breast cancer	4.87e-05	0.000312	CbGpPWpGaD
Gabapentin—Loss of consciousness—Epirubicin—breast cancer	4.87e-05	6.68e-05	CcSEcCtD
Gabapentin—Cough—Epirubicin—breast cancer	4.84e-05	6.63e-05	CcSEcCtD
Gabapentin—Anaphylactic shock—Methotrexate—breast cancer	4.84e-05	6.63e-05	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—breast cancer	4.84e-05	6.63e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PLG—breast cancer	4.82e-05	0.000308	CbGpPWpGaD
Gabapentin—Asthenia—Docetaxel—breast cancer	4.81e-05	6.6e-05	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—breast cancer	4.8e-05	6.58e-05	CcSEcCtD
Gabapentin—Infection—Methotrexate—breast cancer	4.8e-05	6.58e-05	CcSEcCtD
Gabapentin—Hypertension—Epirubicin—breast cancer	4.79e-05	6.56e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Capecitabine—breast cancer	4.79e-05	6.56e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AKT2—breast cancer	4.77e-05	0.000305	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Doxorubicin—breast cancer	4.76e-05	6.52e-05	CcSEcCtD
Gabapentin—Pruritus—Docetaxel—breast cancer	4.75e-05	6.5e-05	CcSEcCtD
Gabapentin—Nervous system disorder—Methotrexate—breast cancer	4.74e-05	6.5e-05	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—breast cancer	4.74e-05	6.5e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGF10—breast cancer	4.74e-05	0.000303	CbGpPWpGaD
Gabapentin—Thrombocytopenia—Methotrexate—breast cancer	4.73e-05	6.49e-05	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—breast cancer	4.72e-05	6.47e-05	CcSEcCtD
Gabapentin—Myalgia—Epirubicin—breast cancer	4.72e-05	6.47e-05	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—breast cancer	4.72e-05	6.47e-05	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—breast cancer	4.71e-05	6.46e-05	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—breast cancer	4.7e-05	6.45e-05	CcSEcCtD
Gabapentin—Nausea—Paclitaxel—breast cancer	4.7e-05	6.44e-05	CcSEcCtD
Gabapentin—Skin disorder—Methotrexate—breast cancer	4.7e-05	6.44e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.69e-05	6.42e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Methotrexate—breast cancer	4.67e-05	6.41e-05	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—breast cancer	4.66e-05	6.39e-05	CcSEcCtD
Gabapentin—Asthenia—Capecitabine—breast cancer	4.66e-05	6.39e-05	CcSEcCtD
Gabapentin—Malaise—Doxorubicin—breast cancer	4.63e-05	6.34e-05	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—breast cancer	4.62e-05	6.33e-05	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—breast cancer	4.61e-05	6.32e-05	CcSEcCtD
Gabapentin—Anorexia—Methotrexate—breast cancer	4.61e-05	6.32e-05	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—breast cancer	4.6e-05	6.3e-05	CcSEcCtD
Gabapentin—Pruritus—Capecitabine—breast cancer	4.6e-05	6.3e-05	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—breast cancer	4.59e-05	6.29e-05	CcSEcCtD
Gabapentin—Diarrhoea—Docetaxel—breast cancer	4.59e-05	6.29e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—breast cancer	4.58e-05	0.000293	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFA—breast cancer	4.58e-05	0.000293	CbGpPWpGaD
Gabapentin—Confusional state—Epirubicin—breast cancer	4.56e-05	6.25e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—breast cancer	4.56e-05	0.000292	CbGpPWpGaD
Gabapentin—Palpitations—Doxorubicin—breast cancer	4.53e-05	6.21e-05	CcSEcCtD
Gabapentin—Oedema—Epirubicin—breast cancer	4.53e-05	6.2e-05	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—breast cancer	4.53e-05	6.2e-05	CcSEcCtD
Gabapentin—Hypotension—Methotrexate—breast cancer	4.52e-05	6.19e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TGFBR2—breast cancer	4.51e-05	0.000289	CbGpPWpGaD
Gabapentin—Loss of consciousness—Doxorubicin—breast cancer	4.51e-05	6.18e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ALB—breast cancer	4.5e-05	0.000288	CbGpPWpGaD
Gabapentin—Infection—Epirubicin—breast cancer	4.5e-05	6.16e-05	CcSEcCtD
Gabapentin—Cough—Doxorubicin—breast cancer	4.48e-05	6.13e-05	CcSEcCtD
Gabapentin—Shock—Epirubicin—breast cancer	4.45e-05	6.1e-05	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—breast cancer	4.45e-05	6.09e-05	CcSEcCtD
Gabapentin—Diarrhoea—Capecitabine—breast cancer	4.44e-05	6.09e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ITPR1—breast cancer	4.44e-05	0.000284	CbGpPWpGaD
Gabapentin—Nervous system disorder—Epirubicin—breast cancer	4.44e-05	6.08e-05	CcSEcCtD
Gabapentin—Dizziness—Docetaxel—breast cancer	4.44e-05	6.08e-05	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—breast cancer	4.43e-05	6.07e-05	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—breast cancer	4.43e-05	6.07e-05	CcSEcCtD
Gabapentin—Tachycardia—Epirubicin—breast cancer	4.42e-05	6.05e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ERBB4—breast cancer	4.41e-05	0.000282	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT5A—breast cancer	4.41e-05	0.000282	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP3—breast cancer	4.41e-05	0.000282	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Methotrexate—breast cancer	4.41e-05	6.04e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—breast cancer	4.4e-05	0.000281	CbGpPWpGaD
Gabapentin—Skin disorder—Epirubicin—breast cancer	4.4e-05	6.02e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Epirubicin—breast cancer	4.37e-05	5.99e-05	CcSEcCtD
Gabapentin—Insomnia—Methotrexate—breast cancer	4.37e-05	5.99e-05	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—breast cancer	4.37e-05	5.99e-05	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—breast cancer	4.37e-05	5.99e-05	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—breast cancer	4.37e-05	5.99e-05	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—breast cancer	4.35e-05	5.96e-05	CcSEcCtD
Gabapentin—Paraesthesia—Methotrexate—breast cancer	4.34e-05	5.95e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.34e-05	5.94e-05	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—breast cancer	4.32e-05	5.91e-05	CcSEcCtD
Gabapentin—Anorexia—Epirubicin—breast cancer	4.31e-05	5.91e-05	CcSEcCtD
Gabapentin—Dyspnoea—Methotrexate—breast cancer	4.31e-05	5.91e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—NOS3—breast cancer	4.31e-05	0.000275	CbGpPWpGaD
Gabapentin—Somnolence—Methotrexate—breast cancer	4.3e-05	5.89e-05	CcSEcCtD
Gabapentin—Dizziness—Capecitabine—breast cancer	4.3e-05	5.89e-05	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—breast cancer	4.27e-05	5.85e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SMAD4—breast cancer	4.27e-05	0.000273	CbGpPWpGaD
Gabapentin—Vomiting—Docetaxel—breast cancer	4.27e-05	5.85e-05	CcSEcCtD
Gabapentin—Dyspepsia—Methotrexate—breast cancer	4.26e-05	5.83e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—IGF1R—breast cancer	4.24e-05	0.000271	CbGpPWpGaD
Gabapentin—Rash—Docetaxel—breast cancer	4.23e-05	5.8e-05	CcSEcCtD
Gabapentin—Hypotension—Epirubicin—breast cancer	4.23e-05	5.79e-05	CcSEcCtD
Gabapentin—Dermatitis—Docetaxel—breast cancer	4.23e-05	5.79e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—breast cancer	4.22e-05	0.00027	CbGpPWpGaD
Gabapentin—Confusional state—Doxorubicin—breast cancer	4.22e-05	5.79e-05	CcSEcCtD
Gabapentin—Decreased appetite—Methotrexate—breast cancer	4.2e-05	5.76e-05	CcSEcCtD
Gabapentin—Headache—Docetaxel—breast cancer	4.2e-05	5.76e-05	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—breast cancer	4.19e-05	5.74e-05	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—breast cancer	4.19e-05	5.74e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Methotrexate—breast cancer	4.17e-05	5.72e-05	CcSEcCtD
Gabapentin—Fatigue—Methotrexate—breast cancer	4.17e-05	5.71e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HES1—breast cancer	4.17e-05	0.000267	CbGpPWpGaD
Gabapentin—Infection—Doxorubicin—breast cancer	4.16e-05	5.7e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PLA2G4A—breast cancer	4.14e-05	0.000265	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCOR1—breast cancer	4.14e-05	0.000265	CbGpPWpGaD
Gabapentin—Pain—Methotrexate—breast cancer	4.14e-05	5.67e-05	CcSEcCtD
Gabapentin—Vomiting—Capecitabine—breast cancer	4.13e-05	5.66e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Epirubicin—breast cancer	4.12e-05	5.65e-05	CcSEcCtD
Gabapentin—Shock—Doxorubicin—breast cancer	4.12e-05	5.64e-05	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—breast cancer	4.11e-05	5.63e-05	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—breast cancer	4.1e-05	5.62e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CSF2—breast cancer	4.1e-05	0.000262	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF1—breast cancer	4.1e-05	0.000262	CbGpPWpGaD
Gabapentin—Rash—Capecitabine—breast cancer	4.1e-05	5.61e-05	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—breast cancer	4.09e-05	5.61e-05	CcSEcCtD
Gabapentin—Dermatitis—Capecitabine—breast cancer	4.09e-05	5.61e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—RAF1—breast cancer	4.09e-05	0.000262	CbGpPWpGaD
Gabapentin—Tachycardia—Doxorubicin—breast cancer	4.09e-05	5.6e-05	CcSEcCtD
Gabapentin—Headache—Capecitabine—breast cancer	4.07e-05	5.58e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NRG1—breast cancer	4.07e-05	0.00026	CbGpPWpGaD
Gabapentin—Skin disorder—Doxorubicin—breast cancer	4.07e-05	5.57e-05	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—breast cancer	4.06e-05	5.57e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—breast cancer	4.05e-05	5.55e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—H2AFX—breast cancer	4.04e-05	0.000258	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—breast cancer	4.04e-05	0.000258	CbGpPWpGaD
Gabapentin—Dyspnoea—Epirubicin—breast cancer	4.03e-05	5.53e-05	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—breast cancer	4.02e-05	5.51e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—E2F1—breast cancer	4.01e-05	0.000257	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—breast cancer	4e-05	0.000256	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—breast cancer	3.99e-05	0.000255	CbGpPWpGaD
Gabapentin—Anorexia—Doxorubicin—breast cancer	3.99e-05	5.47e-05	CcSEcCtD
Gabapentin—Nausea—Docetaxel—breast cancer	3.99e-05	5.46e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Methotrexate—breast cancer	3.98e-05	5.46e-05	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—breast cancer	3.98e-05	5.46e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—breast cancer	3.97e-05	0.000254	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Methotrexate—breast cancer	3.95e-05	5.42e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PTGS2—breast cancer	3.94e-05	0.000252	CbGpPWpGaD
Gabapentin—Decreased appetite—Epirubicin—breast cancer	3.93e-05	5.39e-05	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—breast cancer	3.91e-05	5.36e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—breast cancer	3.91e-05	5.35e-05	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—breast cancer	3.9e-05	5.35e-05	CcSEcCtD
Gabapentin—Constipation—Epirubicin—breast cancer	3.87e-05	5.3e-05	CcSEcCtD
Gabapentin—Pain—Epirubicin—breast cancer	3.87e-05	5.3e-05	CcSEcCtD
Gabapentin—Nausea—Capecitabine—breast cancer	3.86e-05	5.29e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SPP1—breast cancer	3.85e-05	0.000246	CbGpPWpGaD
Gabapentin—Urticaria—Methotrexate—breast cancer	3.84e-05	5.26e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—breast cancer	3.84e-05	0.000245	CbGpPWpGaD
Gabapentin—Abdominal pain—Methotrexate—breast cancer	3.82e-05	5.24e-05	CcSEcCtD
Gabapentin—Body temperature increased—Methotrexate—breast cancer	3.82e-05	5.24e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.81e-05	5.23e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ERBB3—breast cancer	3.81e-05	0.000244	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGFR2—breast cancer	3.81e-05	0.000243	CbGpPWpGaD
Gabapentin—Insomnia—Doxorubicin—breast cancer	3.79e-05	5.19e-05	CcSEcCtD
Gabapentin—Paraesthesia—Doxorubicin—breast cancer	3.76e-05	5.15e-05	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—breast cancer	3.73e-05	5.12e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—breast cancer	3.73e-05	5.11e-05	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—breast cancer	3.72e-05	5.1e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Epirubicin—breast cancer	3.7e-05	5.07e-05	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—breast cancer	3.69e-05	5.05e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IL2—breast cancer	3.67e-05	0.000235	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—breast cancer	3.65e-05	0.000234	CbGpPWpGaD
Gabapentin—Decreased appetite—Doxorubicin—breast cancer	3.64e-05	4.99e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—breast cancer	3.61e-05	4.95e-05	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—breast cancer	3.61e-05	4.95e-05	CcSEcCtD
Gabapentin—Urticaria—Epirubicin—breast cancer	3.59e-05	4.93e-05	CcSEcCtD
Gabapentin—Pain—Doxorubicin—breast cancer	3.58e-05	4.91e-05	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—breast cancer	3.58e-05	4.91e-05	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—breast cancer	3.58e-05	4.9e-05	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—breast cancer	3.58e-05	4.9e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Methotrexate—breast cancer	3.56e-05	4.88e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGFR1—breast cancer	3.55e-05	0.000227	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—breast cancer	3.49e-05	0.000223	CbGpPWpGaD
Gabapentin—Asthenia—Methotrexate—breast cancer	3.47e-05	4.75e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Doxorubicin—breast cancer	3.45e-05	4.73e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PTEN—breast cancer	3.43e-05	0.00022	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Doxorubicin—breast cancer	3.42e-05	4.69e-05	CcSEcCtD
Gabapentin—Pruritus—Methotrexate—breast cancer	3.42e-05	4.69e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—LEP—breast cancer	3.41e-05	0.000218	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CAV1—breast cancer	3.38e-05	0.000216	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—breast cancer	3.34e-05	0.000214	CbGpPWpGaD
Gabapentin—Hypersensitivity—Epirubicin—breast cancer	3.33e-05	4.57e-05	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—breast cancer	3.33e-05	4.56e-05	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—breast cancer	3.31e-05	4.54e-05	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—breast cancer	3.31e-05	4.54e-05	CcSEcCtD
Gabapentin—Diarrhoea—Methotrexate—breast cancer	3.31e-05	4.53e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—AKT1—breast cancer	3.27e-05	0.000209	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—breast cancer	3.26e-05	0.000208	CbGpPWpGaD
Gabapentin—Asthenia—Epirubicin—breast cancer	3.25e-05	4.45e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FN1—breast cancer	3.22e-05	0.000206	CbGpPWpGaD
Gabapentin—Pruritus—Epirubicin—breast cancer	3.2e-05	4.39e-05	CcSEcCtD
Gabapentin—Dizziness—Methotrexate—breast cancer	3.2e-05	4.38e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NFKBIA—breast cancer	3.18e-05	0.000203	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH1—breast cancer	3.15e-05	0.000201	CbGpPWpGaD
Gabapentin—Diarrhoea—Epirubicin—breast cancer	3.1e-05	4.24e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—breast cancer	3.08e-05	4.23e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—breast cancer	3.08e-05	0.000197	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KIT—breast cancer	3.08e-05	0.000197	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APC—breast cancer	3.08e-05	0.000197	CbGpPWpGaD
Gabapentin—Vomiting—Methotrexate—breast cancer	3.07e-05	4.21e-05	CcSEcCtD
Gabapentin—Rash—Methotrexate—breast cancer	3.05e-05	4.18e-05	CcSEcCtD
Gabapentin—Dermatitis—Methotrexate—breast cancer	3.05e-05	4.17e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—EGF—breast cancer	3.04e-05	0.000195	CbGpPWpGaD
Gabapentin—Headache—Methotrexate—breast cancer	3.03e-05	4.15e-05	CcSEcCtD
Gabapentin—Asthenia—Doxorubicin—breast cancer	3e-05	4.12e-05	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—breast cancer	2.99e-05	4.1e-05	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—breast cancer	2.96e-05	4.06e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—MAPK3—breast cancer	2.95e-05	0.000189	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BRAF—breast cancer	2.89e-05	0.000185	CbGpPWpGaD
Gabapentin—Vomiting—Epirubicin—breast cancer	2.88e-05	3.94e-05	CcSEcCtD
Gabapentin—Nausea—Methotrexate—breast cancer	2.87e-05	3.94e-05	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—breast cancer	2.86e-05	3.93e-05	CcSEcCtD
Gabapentin—Rash—Epirubicin—breast cancer	2.85e-05	3.91e-05	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—breast cancer	2.85e-05	3.91e-05	CcSEcCtD
Gabapentin—Headache—Epirubicin—breast cancer	2.83e-05	3.88e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—IGF1—breast cancer	2.82e-05	0.00018	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT2—breast cancer	2.82e-05	0.00018	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—breast cancer	2.8e-05	0.000179	CbGpPWpGaD
Gabapentin—Dizziness—Doxorubicin—breast cancer	2.77e-05	3.79e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—breast cancer	2.71e-05	0.000173	CbGpPWpGaD
Gabapentin—Nausea—Epirubicin—breast cancer	2.69e-05	3.68e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—breast cancer	2.68e-05	0.000171	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—breast cancer	2.68e-05	0.000171	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—breast cancer	2.66e-05	3.65e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—breast cancer	2.65e-05	0.000169	CbGpPWpGaD
Gabapentin—Rash—Doxorubicin—breast cancer	2.64e-05	3.62e-05	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—breast cancer	2.64e-05	3.61e-05	CcSEcCtD
Gabapentin—Headache—Doxorubicin—breast cancer	2.62e-05	3.59e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NOS3—breast cancer	2.55e-05	0.000163	CbGpPWpGaD
Gabapentin—Nausea—Doxorubicin—breast cancer	2.49e-05	3.41e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—breast cancer	2.43e-05	0.000156	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MDM2—breast cancer	2.42e-05	0.000155	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—breast cancer	2.42e-05	0.000155	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAF1—breast cancer	2.42e-05	0.000155	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RELA—breast cancer	2.4e-05	0.000154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—breast cancer	2.39e-05	0.000153	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTOR—breast cancer	2.36e-05	0.000151	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—breast cancer	2.36e-05	0.000151	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—breast cancer	2.27e-05	0.000145	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—breast cancer	2.25e-05	0.000144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—breast cancer	2.21e-05	0.000142	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—breast cancer	2.19e-05	0.00014	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—breast cancer	2.17e-05	0.000139	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—breast cancer	2.17e-05	0.000139	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—breast cancer	2.15e-05	0.000138	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—breast cancer	2.11e-05	0.000135	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUN—breast cancer	2.11e-05	0.000135	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNB1—breast cancer	2.09e-05	0.000134	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—breast cancer	2.05e-05	0.000131	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1A—breast cancer	2.04e-05	0.000131	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—breast cancer	2.04e-05	0.00013	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK8—breast cancer	1.99e-05	0.000128	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—breast cancer	1.99e-05	0.000127	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—breast cancer	1.98e-05	0.000127	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SRC—breast cancer	1.89e-05	0.000121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—breast cancer	1.84e-05	0.000118	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—breast cancer	1.82e-05	0.000117	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK3—breast cancer	1.74e-05	0.000111	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—breast cancer	1.69e-05	0.000108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—breast cancer	1.69e-05	0.000108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—breast cancer	1.66e-05	0.000106	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—breast cancer	1.56e-05	0.0001	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—breast cancer	1.44e-05	9.2e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—breast cancer	1.39e-05	8.9e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—breast cancer	1.33e-05	8.51e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—breast cancer	1.27e-05	8.14e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—breast cancer	1.17e-05	7.51e-05	CbGpPWpGaD
